{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:22:14Z","timestamp":1777940534861,"version":"3.51.4"},"reference-count":54,"publisher":"SAGE Publications","issue":"10","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Thyroid\u00ae"],"published-print":{"date-parts":[[2013,10]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>The purpose of this study was to examine the utility of remnant uptake on postoperative radioiodine scans as an oncologic indicator after thyroidectomy for differentiated thyroid cancer (DTC).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We conducted a retrospective review of patients undergoing total thyroidectomy for DTC and subsequent radioactive iodine (RAI) treatment. Of the eight surgeons included, three were considered high volume, performing at least 20 thyroidectomies per year. Patients with distant metastases at diagnosis or poorly differentiated variants were excluded. To control for the effect of varying RAI doses, the remnant uptake was analyzed as a ratio of the percentage uptake to the dose received (uptake to dose ratio [UDR]). Multivariate logistic regression was used to determine the influence of UDR on recurrence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Of the 223 patients who met inclusion criteria, 21 patients (9.42%) experienced a recurrence. Those with a recurrence had a 10-fold higher UDR compared with those who did not (0.030 vs. 0.003,\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      =0.001). Similarly, patients with increasing postoperative thyroglobulin measurements (0.339 vs. 0.003,\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      &lt;0.001) also had significantly greater UDRs compared with those with stable thyroglobulin. The UDRs of high-volume surgeons were significantly smaller than low-volume surgeons (0.003 vs. 0.025,\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      =0.002). When combined with other known predictors for recurrence, UDR (OR 3.71 [95%CI 1.05\u201313.10],\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      =0.041) was significantly associated with recurrence. High-volume surgeons maintained a low level of permanent complications across all UDRs, whereas low-volume surgeons had greater permanent complications associated with higher uptake.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Remnant uptake is a useful postoperative oncologic quality indicator that can predict a patient's risk of disease recurrence and indicate the completeness of resection.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1089\/thy.2012.0451","type":"journal-article","created":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T13:08:18Z","timestamp":1359724098000},"page":"1269-1276","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":46,"title":["Remnant Uptake as a Postoperative Oncologic Quality Indicator"],"prefix":"10.1177","volume":"23","author":[{"given":"David F.","family":"Schneider","sequence":"first","affiliation":[{"name":"University of Wisconsin"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristin A.","family":"Ojomo","sequence":"additional","affiliation":[{"name":"University of Wisconsin"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herbert","family":"Chen","sequence":"additional","affiliation":[{"name":"University of Wisconsin"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca S.","family":"Sippel","sequence":"additional","affiliation":[{"name":"University of Wisconsin"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2013,10,1]]},"reference":[{"key":"e_1_3_3_2_2","volume-title":"SEER cancer statistics review","year":"1975","unstructured":"National Cancer Institute. SEER cancer statistics review, 1975\u20132005. National Cancer Institute: Bethesda, MD."},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0b013e31814697d9"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2008.08.035"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(81)90573-8"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-197705000-00001"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(94)90321-2"},{"key":"e_1_3_3_8_2","first-page":"1050","article-title":"Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989","volume":"114","author":"Hay ID","year":"1993","unstructured":"Hay ID, , Bergstralh EJ, , Goellner JR, , Ebersold JR, , Grant CS. 1993. Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery, 114:1050\u20131057; discussion 1057\u20131058.","journal-title":"Surgery"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0039-6060(98)70035-2"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2009.0110"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2006.16.1229"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/hed.21504"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2011.08.016"},{"key":"e_1_3_3_14_2","first-page":"579","article-title":"What is the optimal initial treatment of low-risk papillary thyroid cancer (and why is it controversial)?","volume":"23","author":"Mazzaferri EL","year":"2009","unstructured":"Mazzaferri EL. 2009. What is the optimal initial treatment of low-risk papillary thyroid cancer (and why is it controversial)? Oncology (Williston Park), 23:579\u2013588.","journal-title":"Oncology (Williston Park)"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9610(05)80326-5"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02303583"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2007.09.003"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1001\/archoto.2010.212"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jss.2010.03.059"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d8041"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0039-6060(03)00420-3"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-199809000-00005"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-198209000-00016"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0039-6109(16)44181-2"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1259\/0007-1285-65-778-905"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9610(79)90418-5"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-031167"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.4158\/EP.12.1.63"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2009.1606"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1089\/thy.1997.7.273"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecl.2007.04.006"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0022215107008997"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2011.02.021"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4741.2007.00415.x"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2005.0024"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-012-2802-8"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1177\/000313481007600107"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-011-2105-5"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2012-0240"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2009.0259"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(08)70276-6"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2010-1500"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.295.18.2164"},{"key":"e_1_3_3_44_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.167.18.1958"},{"key":"e_1_3_3_45_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-199809000-00016"},{"key":"e_1_3_3_46_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-199511000-00006"},{"key":"e_1_3_3_47_2","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.7111"},{"key":"e_1_3_3_48_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.24185"},{"key":"e_1_3_3_49_2","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-010-1337-0"},{"key":"e_1_3_3_50_2","doi-asserted-by":"publisher","DOI":"10.1007\/DCR.0b013e31819edb7d"},{"key":"e_1_3_3_51_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2008.07.012"},{"key":"e_1_3_3_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjsurg.2011.12.020"},{"key":"e_1_3_3_53_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2011.140"},{"key":"e_1_3_3_54_2","first-page":"490719","article-title":"Technological innovations in surgical approach for thyroid cancer","author":"Lang BH","year":"2010","unstructured":"Lang BH, , Lo CY. 2010. Technological innovations in surgical approach for thyroid cancer. J Oncol, 2010; pii:490719.","journal-title":"J Oncol"},{"key":"e_1_3_3_55_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19990801)86:3<538::AID-CNCR25>3.0.CO;2-K"}],"container-title":["Thyroid\u00ae"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/thy.2012.0451","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/thy.2012.0451","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/thy.2012.0451","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T05:53:05Z","timestamp":1777701185000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1089\/thy.2012.0451"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":54,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["10.1089\/thy.2012.0451"],"URL":"https:\/\/doi.org\/10.1089\/thy.2012.0451","relation":{},"ISSN":["1050-7256","1557-9077"],"issn-type":[{"value":"1050-7256","type":"print"},{"value":"1557-9077","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10]]}}}